Our laboratory is focusing on identification of metastasis and tumor cell invasion-associated molecules, by using advanced molecular biology and the phage display technology. We are also developing outstanding cellular and pre-clinical models of the disease, using patient-derived tumor cells from brain metastatic lesions, primary brain cancers or peripheral neoplasms such as breast, lungs or melanoma tumors.